① BYD Co., Ltd. sold 302,500 new energy vehicles in March, up 46.06% year on year; ② COSCO Haineng's profit more than doubled last year. How big is the profit scale?
Recent important announcements for Hong Kong stocks are as follows:
Operational data
$BYD COMPANY (01211.HK)$In March, sales of new energy vehicles were 302,500 units, up 46.06% year on year.
$LI AUTO-W (02015.HK)$In March, 28,984 new vehicles were delivered, an increase of 39.2% over the previous year.
$NIO-SW (09866.HK)$In March, 11,866 vehicles were delivered, up 14.3% year over year.
$XPENG-W (09868.HK)$In March, 9,026 new vehicles were delivered, up 99% month-on-month and 29% year-on-year.
$GWMOTOR (02333.HK)$Sales in March were 100,276 units, up 11.02% year over year.
Results Express
$CHINA RAIL CONS (01186.HK)$: In 2023, revenue was 1137.993 billion yuan, up 3.8% year on year; net profit was 26.097 billion yuan, down 2.19% year on year.
In 2023, the Group signed a total of 3293.87 billion yuan of new contracts, an increase of 1.51% over the previous year. As of December 31, 2023, the total amount of unfinished contracts of the Group was 668.89,825.3 billion yuan, an increase of 5.14% over the previous year.
$BANK OF CHINA (03988.HK)$: 2023 revenue of 624.138 billion yuan, up 6.42% year on year; net profit of 231.904 billion yuan, up 2.38% year on year.
$PSBC (01658.HK)$: 2023 revenue of 342,912 billion yuan, up 0.24% year on year; net profit of 86.27 billion yuan, up 1.23% year on year.
$GWMOTOR (02333.HK)$: Total revenue in 2023 was approximately RMB 173.212 billion, up 26.12% year on year; net profit was about RMB 7.022 billion, down 15.06% year on year.
$CHINA RES GAS (01193.HK)$: Revenue of HK$101,272 billion in 2023, up 7.35% year on year; net profit of HK$5.223 billion, up 10.36% year on year. The Group's overall gross margin was 18.2%, down 1 percentage point from the same period last year.
$ZHONGLIANG HLDG (02772.HK)$: Revenue in 2023 was about 66.62 billion yuan, an increase of about 69.4% year-on-year; net loss was 4.25 billion yuan, an increase of 215.3% over the previous year.
$ZOOMLION (01157.HK)$: 2023 revenue of 47.075 billion yuan, up 13.08% year on year; net profit of 3.55 billion yuan, up 51.26% year on year.
$COSCO SHIP ENGY (01138.HK)$: 2023 revenue of 21.912 billion yuan, up 18.02% year on year; net profit of 3.349 billion yuan, up 129.23% year on year.
In 2023, the transportation volume was 172.593 million tons, a year-on-year decrease of 1.0%; the transportation turnover (excluding term leases) was 530.49 billion tonnes, a decrease of 1.2% year-on-year;
$JOY CITY PPT (00207.HK)$: 2023 revenue of 13.272 billion yuan, a year-on-year decrease of 36.3%; net profit of 340 million yuan, a year-on-year decrease of 35.94%.
$BEIGENE (06160.HK)$: Total revenue for 2023 was US$2,459 million, up 73.65% year over year. For the year ended December 31, 2023, Baiyuze's global sales totaled US$1.3 billion, an increase of 128.5% over the previous year.
$FENBI (02469.HK)$: In 2023, we achieved revenue of 3.02 billion yuan, gross profit of 1.57 billion yuan, an increase of 14.9% year on year; adjusted net profit of 450 million yuan, an increase of 134.1% year on year.
$SINO BIOPHARM (01177.HK)$: In 2023, continuous operating revenue was RMB 26.199 billion, up 0.67% year on year; net profit was RMB 2,332 billion, down 8.32% year on year.
$HEC CJ PHARM (01558.HK)$: In 2023, revenue was 6.295 billion yuan, up 68.08% year on year, and net profit was 1,993 billion yuan, up 2501.23% year on year.
Sales of the core product Kewei (oseltamivir phosphate capsules and granules) were 5.509.5 billion yuan, an increase of 78.15% over the same period last year.
$CHENMING PAPER (01812.HK)$: 2023 revenue of 26.609 billion yuan, a year-on-year decrease of 16.86%; net loss of 1,281 billion yuan.
$SHIMAO SERVICES (00873.HK)$: In 2023, revenue was 8.203 billion yuan, and net profit was 273 million yuan, turning a year-on-year loss into a profit.
$SHANDONG XINHUA (00719.HK)$: Revenue in 2023 was about 8.1 billion yuan, up 7.97% year on year; net profit was about 496.5 million yuan, up 20.79% year on year.
$TIGERMED (03347.HK)$: 2023 revenue of 7.384 billion yuan, up 4.2% year on year; net profit of 2,026.5 billion yuan, up 0.5% year on year.
$ASYMCHEM (06821.HK)$: Revenue of 2023 was about 7.781 billion yuan, a year-on-year decrease of 23.94%; net profit of 2,269 billion yuan, a year-on-year decrease of 31.28%. Excluding orders for which revenue has been confirmed during the reporting period, the company still has $874 million in on-hand orders.
$KEEP (03650.HK)$: Revenue of $2,138 billion in 2023, a year-on-year decrease of 3.3%; net profit of $1,106 billion, loss of $105.5 million.
Buyback News
$TENCENT (00700.HK)$: On March 28, HK$1.03 billion was spent to repurchase 3.28 million shares at a repurchase price of HK$301.8-308.6.
$XIAOMI-W (01810.HK)$: On March 28, HK$52.4332 million was spent to repurchase 350,000 shares at a repurchase price of HK$14.94-15.00.
$CK ASSET (01113.HK)$: On March 28, HK$120 million was spent to repurchase 3.719 million shares at a repurchase price of HK$32.05-32.3.
$HSBC HOLDINGS (00005.HK)$: Approximately HK$273 million was spent to repurchase 4.448,800 shares at a repurchase price of HK$61.25-HK$61.75.
$AIA (01299.HK)$: Spend HK$28.554,500 to repurchase 550,000 shares at a repurchase price of HK$50.2-52.95.
$GUSHENGTANG (02273.HK)$: Spend HK$21.835,800 to repurchase 49,400 shares at a repurchase price of HK$43.2-44.1.
edit/new